NAS:CHNA

Loncar China BioPharma ETF

$ 14.2492 0 ( +0%) 03:51 PM EST
PE Ratio:
0
PB Ratio:
0
Volume:
70.00
Dividend Yield %:
0.5
Last Holding update 2023-10-31 66 Stocks (0 new)
Value $4.00 Mil Turnover 0 %
Top Holdings: HKSE:06660(4.49%) LEGN(3.09%) HKSE:02359(2.72%) HKSE:01099(2.58%) HKSE:06826(2.49%)
Portfolio Report
Registrant: ETF Series Solutions
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Performance Chart Fundamental Charts Technical Indicators Gurus Trades Top Holdings Sector Breakdowns Holding History Back to Top

Loncar China BioPharma ETF Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

Loncar China BioPharma ETF Key Statistics

Name Value
Day's Open ($) 14.2492
Day's Range ($) 14.2492 - 14.2492
Day's Volume 70
52-Week Range ($) 13.351 - 22.89
Beta -
3-Year Sharpe Ratio -0.67
3-Year Sortino Ratio -0.85
Volatility -
14-Day RSI -
14-Day ATR ($) 0.134286
20-Day SMA ($) -

Fundamental Data

Name Value
Market Cap (Mil $) 3.721
Shares Outstanding (Mil) -
PE Ratio -
PE Ratio (10y Range) 9.4 - 19.4
PE Ratio (10y Median) 17.6
PB Ratio -
PB Ratio (10y Range) 1.49 - 3.73
PB Ratio (10y Median) 2.88

Dividend Data

Name Value
Dividends per Share (TTM) ($) 0.067
Dividend Yield % 0.5
Dividend Yield % (10y Range) 0.12 - 22.44
Dividend Yield % (10y Median) 0.5
Next Dividend Payment Date
Dividend Frequency Annually

CHNA Loncar China BioPharma ETF Fundamental Charts

Historical TTM Price-to-Earnings for CHNA Loncar China BioPharma ETF

Historical TTM Price-to-Earnings without NRI for CHNA Loncar China BioPharma ETF

Historical Price-to-Book Ratio for CHNA Loncar China BioPharma ETF

Historical Dividend Yields for CHNA Loncar China BioPharma ETF

Loncar China BioPharma ETF Technical Indicators

Moving Average

Momentum

Gurus Latest Trades with NAS:CHNA

No Available Data

NAS:CHNA is held by these investors

No Available Data
Loncar China BioPharma ETF Top Holdings of 2023-08-31 View Full List
Ticker
Company
Shares
Value ($1000)
Shares Change %
Weighting %
Trade Impact %
% of Shares outstanding
3M Change %
YTD Change %
Market Cap $Mil
Industry
HKSE:06660
AIM Vaccine Co Ltd
29,400
185.2
0%
4.490
0%
0.000
+46.31%
-19.22%
6,083.8
Biotechnology
LEGN
Legend Biotech Corp
1,841
127.7
0%
3.090
0%
0.000
+29.21%
+36.20%
8,156.2
Biotechnology
HKSE:02359
Wuxi AppTec Co Ltd
10,257
112.4
0%
2.720
0%
0.000
+71.36%
+75.92%
274,067.9
Medical Diagnostics & Research
HKSE:01099
Sinopharm Group Co Ltd
36,700
106.5
0%
2.580
0%
0.000
+15.06%
-6.13%
60,415.9
Medical Distribution
ONC
BeiGene Ltd
507
105.2
0%
2.550
0%
0.000
+18.34%
+59.62%
33,587.6
Biotechnology
HKSE:06826
Shanghai Haohai Biological Technology Co Ltd
Shanghai Haohai Biological Technology Co Ltd
25,480
102.6
0%
2.490
0%
0.010
+26.51%
+16.03%
12,849.0
Biotechnology
HKSE:02196
Shanghai Fosun Pharmaceutical (Group) Co Ltd
Shanghai Fosun Pharmaceutical (Group) Co Ltd
40,500
95.3
0%
2.310
0%
0.000
+27.44%
+33.77%
71,649.6
Drug Manufacturers
HKSE:00874
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
31,000
87.2
0%
2.110
0%
0.000
+13.85%
+4.84%
46,243.0
Medical Distribution
HKSE:02607
Shanghai Pharmaceuticals Holding Co Ltd
Shanghai Pharmaceuticals Holding Co Ltd
51,700
85.0
0%
2.060
0%
0.000
+21.51%
+3.79%
70,460.7
Medical Distribution
HKSE:02269
WuXi Biologics (Cayman) Inc
15,000
84.5
0%
2.050
0%
0.000
+30.63%
+69.60%
120,771.7
Biotechnology

Loncar China BioPharma ETF's Historical Top Holdings Breakdowns

Loncar China BioPharma ETF Total Holding History ($B)

To

Loncar China BioPharma ETF's Asset Allocation

To

Loncar China BioPharma ETF Past Portfolios

Portfolio Date Number of Stocks New Stocks Total Value ($Mil) Q/Q Turnover

Top Ranked Articles

  • 1

Loncar China BioPharma ETF's Hypothetical Growth since 2023-08-31

Loncar China BioPharma ETF's Yearly Returns

Year Portfolio % % Excess Gain %

Loncar China BioPharma ETF's Holdings Heat Map

Size field:

Loncar China BioPharma ETF's Holdings Bubble Chart

Loncar China BioPharma ETF News

  • 1

Discussions on Loncar China BioPharma ETF

User's Avatar
How would you rate this stock? CHNA
No discussions yet.
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2025 GuruFocus.com, LLC. All Rights Reserved.